文献速递乳腺外科

吲哚菁绿近红外荧光淋巴作图在乳腺癌患者中的前瞻性试验

Near Infrared Fluorescent Lymph Node Mapping with Indocyanine Green in Breast Cancer Patients: A Prospective Trial.
PubMed 文献 · J Am Coll Surg · 2018-12-21

结果显示ICG与99mTc表现相似,ICG可安全有效地用于术中实时淋巴作图。

要点

  • ICG近红外荧光淋巴作图在乳腺癌患者中安全有效,可实时指导SLN活检。
  • ICG与99mTc检出的SLN平均数目分别为2.4枚和2.2枚,差异无统计学意义(p=0.34)。
  • ICG识别病理阳性SLN为24/24(100%),99mTc为23/24(96%),p=0.99。

核心结论

  • ICG联合近红外荧光成像可安全有效地用于乳腺癌患者术中实时淋巴作图。
  • ICG在SLN检出数目、失败率和病理阳性SLN识别率方面与99mTc表现相似。

研究设计与样本

  • 术前用99mTc行淋巴作图,术中注射0.8 mL ICG行近红外荧光作图,SLN活检由近红外相机和伽马探头引导。

主要发现

  • ICG从乳腺注射至腋窝定位的平均转运时间为5分钟(范围2至29分钟)。
  • 未观察到ICG相关不良反应。
  • ICG和99mTc检出的SLN平均数目分别为2.4枚(SD 1.42)和2.2枚(SD 1.23),p=0.34。
  • 18例(19.8%)患者检出病理阳性SLN;共24枚阳性SLN,ICG识别24/24(100%),99mTc识别23/24(96%),p=0.99。

临床怎么用

  • 乳腺癌前哨淋巴结活检中可考虑使用ICG近红外荧光淋巴作图作为99mTc的替代或补充手段。
  • ICG作图可提供实时术中可视化,帮助定位腋窝SLN。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Near infrared (NIR) fluorescence imaging is an emerging modality that can enable real-time image-guided procedures. Indocyanine green (ICG) is an FDA-approved, inexpensive, and widely available NIR dye. We hypothesized that axillary lymphatic mapping with ICG is equivalent to lymphatic mapping with technetium 99m (99mTc) in breast cancer patients. STUDY DESIGN: Breast cancer patients (cT1-2, N0) were prospectively enrolled. Patients underwent lymphatic mapping with 99mTc preoperatively and ICG mapping intraoperatively (0.8 mL). Sentinel lymph node (SLN) biopsy was guided by NIR camera and gamma probe. Rate of failed mapping, number of SLNs identified, and rate of identifying pathologically positive SLNs were compared between the 2 techniques (p < 0.05 was considered statistically significant). RESULTS: Ninety-two female patients were enrolled (median age 59 years). Mean transit time from ICG injection in the breast to localization in the axilla was 5 minutes (range 2 to 29 minutes). No adverse reactions to ICG were noted. Mean number of SLNs identified with ICG and 99mTc was 2.4 (SD 1.42) and 2.2 (SD 1.23), respectively (p = 0.34). Pathologically positive SLNs were identified in 18 (19.8%) patients. A total of 24 pathologically positive SLNs in 18 patients were identified by ICG in 24 of 24 (100%) patients and by 99mTc in 23 of 24 (96%) patients (p = 0.99). CONCLUSIONS: Indocyanine green with NIR fluorescence imaging can be safely and efficiently used for real-time intraoperative lymphatic mapping in breast cancer patients. Indocyanine green performs similarly to 99mTc with regard to the number of SLNs identified, rate of failed mapping, and identification of pathologically positive SLNs.

来源:J Am Coll Surg,查看原文。版权归原作者所有。

引用

  1. Valente SA, Al-Hilli Z, Radford DM, et al. Near Infrared Fluorescent Lymph Node Mapping with Indocyanine Green in Breast Cancer Patients: A Prospective Trial. J Am Coll Surg. 2018. PMID: 30582975. doi:10.1016/j.jamcollsurg.2018.12.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。